Lappin JM, Bolton P, Smith G, Chua XY, et al. Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial. Schizophr Res 2026;296:19-28.
PMID: 42372344